Cargando…
Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells
In this study, we investigated the use of metabolic oligosaccharide engineering and bio-orthogonal ligation reactions combined with lectin microarray and mass spectrometry to analyze sialoglycoproteins in the SW1990 human pancreatic cancer line. Specifically, cells were treated with the azido N-acet...
Autores principales: | Tian, Yuan, Almaraz, Ruben T, Choi, Caitlin H, Li, Qing Kay, Saeui, Christopher, Li, Danni, Shah, Punit, Bhattacharya, Rahul, Yarema, Kevin J, Zhang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434541/ https://www.ncbi.nlm.nih.gov/pubmed/25987888 http://dx.doi.org/10.1186/s12014-015-9083-8 |
Ejemplares similares
-
Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells
por: Mathew, Mohit P., et al.
Publicado: (2016) -
Automated synthesis of sialylated oligosaccharides
por: Esposito, Davide, et al.
Publicado: (2012) -
Metabolic Glycoengineering Sensitizes Drug-Resistant Pancreatic Cancer Cells to Tyrosine Kinase Inhibitors Erlotinib and Gefitinib
por: Mathew, Mohit P., et al.
Publicado: (2015) -
Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified N-Acetylmannosamine (ManNAc) Analogs
por: Du, Jian, et al.
Publicado: (2021) -
Cell Surface and Membrane Engineering: Emerging Technologies and Applications
por: Saeui, Christopher T., et al.
Publicado: (2015)